45 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
46
A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A.
U.S. Army Medical Research Institute of Infectious Diseases
2
Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
Brookhaven National Laboratory
11
Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.
Stony Brook University
18
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
The Scripps Research Institute
40
Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria.
University of Belgrade
63
Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain.
The Scripps Research Institute
15
Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain.
The Scripps Research Institute
12
Targeting botulinum A cellular toxicity: a prodrug approach.
The Scripps Research Institute
3
Investigating the selectivity of metalloenzyme inhibitors.
University of California San Diego
1
4-Amino-7-chloroquinolines: probing ligand efficiency provides botulinum neurotoxin serotype A light chain inhibitors with significant antiprotozoal activity.
University of Belgrade
30
Virtual medicinal chemistry: in silico pre-docking functional group transformation for discovery of novel inhibitors of botulinum toxin serotype A light chain.
Panthera Biopharma
22
Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: synthesis, crystallography, modeling, kinetic and cellular based studies.
The Scripps Research Institute
2
Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A.
Lakehead University and Thunder Bay Regional Research Institute
3
The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft.
The Scripps Research Institute
1
Identification of a Natural Product Antagonist against the Botulinum Neurotoxin Light Chain Protease.
TBA
7
The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease.
University of Belgrade
4
Pharmacophore Refinement Guides the Rational Design of Nanomolar-Range Inhibitors of the Botulinum Neurotoxin Serotype A Metalloprotease.
TBA
44
Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: extending towards theß-exosite.
Fox Chase Chemical Diversity Center
35
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
Microbiotix
3
Separation of Betti Reaction Product Enantiomers: Absolute Configuration and Inhibition of Botulinum Neurotoxin A.
U.S. Army Medical Research Institute For Infectious Diseases
30
Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.
Microbiotix
2
A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus.
University of Belgrade
3
Synthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease.
The Scripps Research Institute
6
Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A.
U.S. Army Medical Research Institute of Infectious Diseases
5
Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase.
The Scripps Research Institute
5
Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease.
National Cancer Institute At Frederick
17
Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons.
National Cancer Institute-Frederick
59
Bifunctional Inhibition of Botulinum Neurotoxin A Protease: Unexpected Active Site Inhibition Enhances Covalent Targeting of an Allosteric Site.
The Scripps Research Institute
5
Novel Antimicrobial 8-Hydroxyquinoline-Based Agents: Current Development, Structure-Activity Relationships, and Perspectives.
Universidade Federal Do Rio Grande Do Sul
15
Synthesis and activity evaluation of selenazole-coupled CPI-1 irreversible bifunctional inhibitors for botulinum toxin A light chain.
Guizhou Medical University
11
Identification of Slow-Binding Inhibitors of the BoNT/A Protease.
The Scripps Research Institute
28
Use of Crystallography and Molecular Modeling for the Inhibition of the Botulinum Neurotoxin A Protease.
Scripps Research
1
Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approach.
The Scripps Research Institute
2
Synthesis and activity of isoleucine sulfonamide derivatives as novel botulinum neurotoxin serotype A light chain inhibitors.
California State University
14
Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A.
Boston University School of Medicine
10
Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity.
Stony Brook University
13
Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.
The Scripps Research Institute
23
New Steroidal 4-Aminoquinolines Antagonize Botulinum Neurotoxin Serotype A in Mouse Embryonic Stem Cell Derived Motor Neurons in Postintoxication Model.
University of Belgrade
